Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Al-Khatib

Showing results (111-120 of 143) with videos related to

Pageof 15
Sort By:
Plos One|June 14, 2019
Epidemiology of respiratory infections among adults in Qatar (2012-2017)Hamad Eid Al-Romaihi, Maria K Smatti, Nandakumar Ganesan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 11, 2022
Coronavirus Disease 2019 Disease Severity in Children Infected With the Omicron VariantAdeel A Butt, Soha R Dargham, Srusvin Loka, et al.
JAMA|November 1, 2021
Association of Prior SARS-CoV-2 Infection With Risk of Breakthrough Infection Following mRNA Vaccination in QatarLaith J Abu-Raddad, Hiam Chemaitelly, Houssein H Ayoub, et al.
Nature Communications|January 28, 2022
Relative infectiousness of SARS-CoV-2 vaccine breakthrough infections, reinfections, and primary infectionsLaith J Abu-Raddad, Hiam Chemaitelly, Houssein H Ayoub, et al.
Nature Communications|August 9, 2022
Protection of Omicron sub-lineage infection against reinfection with another Omicron sub-lineageHiam Chemaitelly, Houssein H Ayoub, Peter Coyle, et al.
Journal of Global Health|February 9, 2022
Characterizing the effective reproduction number during the COVID-19 pandemic: Insights from Qatar's experienceRaghid Bsat, Hiam Chemaitelly, Peter Coyle, et al.
The Lancet. Infectious Diseases|February 4, 2023
BNT162b2 antigen dose and SARS-CoV-2 omicron infection in adolescentsHiam Chemaitelly, Houssein H Ayoub, Peter Coyle, et al.
The New England Journal of Medicine|October 12, 2022
Immune Imprinting and Protection against Repeat Reinfection with SARS-CoV-2Hiam Chemaitelly, Houssein H Ayoub, Patrick Tang, et al.
Journal of Travel Medicine|May 29, 2021
Pfizer-BioNTech mRNA BNT162b2 Covid-19 vaccine protection against variants of concern after one versus two dosesLaith J Abu-Raddad, Hiam Chemaitelly, Hadi M Yassine, et al.
Nature Communications|June 2, 2022
Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA.1 and BA.2 subvariants in QatarHiam Chemaitelly, Houssein H Ayoub, Sawsan AlMukdad, et al.
Pageof 15

Showing results (111-120 of 143) with videos related to

Sort By:
Pageof 15
Plos One|June 14, 2019
Epidemiology of respiratory infections among adults in Qatar (2012-2017)Hamad Eid Al-Romaihi, Maria K Smatti, Nandakumar Ganesan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 11, 2022
Coronavirus Disease 2019 Disease Severity in Children Infected With the Omicron VariantAdeel A Butt, Soha R Dargham, Srusvin Loka, et al.
JAMA|November 1, 2021
Association of Prior SARS-CoV-2 Infection With Risk of Breakthrough Infection Following mRNA Vaccination in QatarLaith J Abu-Raddad, Hiam Chemaitelly, Houssein H Ayoub, et al.
Nature Communications|January 28, 2022
Relative infectiousness of SARS-CoV-2 vaccine breakthrough infections, reinfections, and primary infectionsLaith J Abu-Raddad, Hiam Chemaitelly, Houssein H Ayoub, et al.
Nature Communications|August 9, 2022
Protection of Omicron sub-lineage infection against reinfection with another Omicron sub-lineageHiam Chemaitelly, Houssein H Ayoub, Peter Coyle, et al.
Journal of Global Health|February 9, 2022
Characterizing the effective reproduction number during the COVID-19 pandemic: Insights from Qatar's experienceRaghid Bsat, Hiam Chemaitelly, Peter Coyle, et al.
The Lancet. Infectious Diseases|February 4, 2023
BNT162b2 antigen dose and SARS-CoV-2 omicron infection in adolescentsHiam Chemaitelly, Houssein H Ayoub, Peter Coyle, et al.
The New England Journal of Medicine|October 12, 2022
Immune Imprinting and Protection against Repeat Reinfection with SARS-CoV-2Hiam Chemaitelly, Houssein H Ayoub, Patrick Tang, et al.
Journal of Travel Medicine|May 29, 2021
Pfizer-BioNTech mRNA BNT162b2 Covid-19 vaccine protection against variants of concern after one versus two dosesLaith J Abu-Raddad, Hiam Chemaitelly, Hadi M Yassine, et al.
Nature Communications|June 2, 2022
Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA.1 and BA.2 subvariants in QatarHiam Chemaitelly, Houssein H Ayoub, Sawsan AlMukdad, et al.
Pageof 15